Literature DB >> 27695597

Continuous Qualitative Electroencephalography as a Noninvasive Neuromonitor.

Zachary D Threlkeld1, Mohan Kottapally2, Aimee Aysenne3, Nerissa Ko1.   

Abstract

Intracranial pressure (ICP) monitoring frequently guides key decisions in the management of diseases causing intracranial hypertension. Although typically measured by invasive means, contraindications may leave the clinician with little recourse for dynamic ICP evaluation-particularly when the patient's mental status is compromised. We describe here a healthy 18-year-old woman who subacutely progressed to coma due to diffuse cerebral venous sinus thrombosis. Heparinization precluded the use of invasive ICP monitoring, and electroencephalography (EEG) was used novelly as a surrogate ICP monitor. She responded well to anticoagulation and hyperosmolar therapy guided by qualitative EEG and was later discharged with a nearly normal neurologic examination. She was found to have Salmonella bacteremia, heterozygous prothrombin and factor V Leiden mutations, and hemoglobin H disease.

Entities:  

Keywords:  FIRDA; intracranial hypertension; intracranial sinus thrombosis; neuromonitoring

Year:  2016        PMID: 27695597      PMCID: PMC5029552          DOI: 10.1177/1941874416641465

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  15 in total

1.  Monorhythmic frontal delta activity in the human electroencephalogram: a study of 100 cases.

Authors:  J P CORDEAU
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1959-11

2.  Guidelines for the management of severe traumatic brain injury.

Authors: 
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

3.  Clinical and radiologic correlates of frontal intermittent rhythmic delta activity.

Authors:  Nathan Watemberg; Fusun Alehan; Ron Dabby; Tally Lerman-Sagie; Pierre Pavot; Alan Towne
Journal:  J Clin Neurophysiol       Date:  2002-12       Impact factor: 2.177

4.  Electroencephalographic features in posterior fossa tumors in children.

Authors:  J Martinius; A Matthes; C T Lombroso
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1968-08

5.  Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy.

Authors:  F W Sharbrough; J M Messick; T M Sundt
Journal:  Stroke       Date:  1973 Jul-Aug       Impact factor: 7.914

6.  A trial of intracranial-pressure monitoring in traumatic brain injury.

Authors:  Randall M Chesnut; Nancy Temkin; Nancy Carney; Sureyya Dikmen; Carlos Rondina; Walter Videtta; Gustavo Petroni; Silvia Lujan; Jim Pridgeon; Jason Barber; Joan Machamer; Kelley Chaddock; Juanita M Celix; Marianna Cherner; Terence Hendrix
Journal:  N Engl J Med       Date:  2012-12-12       Impact factor: 91.245

7.  The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

Authors:  V De Stefano; I Martinelli; P M Mannucci; K Paciaroni; P Chiusolo; I Casorelli; E Rossi; G Leone
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Neuroradiological correlates of frontally predominant intermittent rhythmic delta activity (FIRDA).

Authors:  R G Fariello; W Orrison; G Blanco; P F Reyes
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-08

Review 10.  Routine intracranial pressure monitoring in acute coma.

Authors:  Rob J Forsyth; Susanne Wolny; Beryl Rodrigues
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17
View more
  1 in total

1.  Early detection of brainstem herniation using electroencephalography monitoring - case report.

Authors:  Naresh Mullaguri; Jonathan M Beary; Christopher R Newey
Journal:  BMC Neurol       Date:  2020-11-07       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.